Improving Cardiopulmonary Bypass: Heparin-Coated Circuits

Journal of Extra-Corporeal Technology

Volumn 35, Issue 4, 2003, Pages 312-316

  Vocelka, Craig ^a   Lindley, Gina ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ANTICOAGULATION; BIOCOMPATIBILITY; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; FOREIGN BODY; HUMAN; INFLAMMATION; MATERIAL COATING; OUTCOMES RESEARCH; POSTOPERATIVE HEMORRHAGE; REVIEW;

EID: 0942265511     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Edmunds LH. Blood-surface interactions during cardiopulmonary bypass. J Card Surg. 1993;8:404-10.
2. Lundblad R, Moen O, Fosse E. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1997;63:1361-7.
3. Moen O, Fosse E, Brockmeier V, et al. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. Ann Thorac Surg. 1995;60:1317-23.
4. Ovrum E, Mollnes TE, Fosse E, et al. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg. 1995;110:1623-32.
5. Videm V, Svennevig JL, Fosse E, et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg. 1992;103:806-13.
6. Ovrum E, Tangen G, Oystese R, Ringdal MAL, Istad R. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. J Thorac Cardiovasc Surg. 2001;121:324-30.
7. Aldea GS, Zhang X, Memmolo CA, et al. Enhanced blood conservation in primary coronary artery bypass surgery using heparin-bonded circuits with lower anticoagulation. J Card Surg. 1996;11:85-95.
8. Aldea GS, O'Gara P, Shapira OM, et al. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg. 1998;65: 425-33.
9. Aldea GS, Doursounian M, O'Gara P. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study. Ann Thorac Surg. 1996;62:410-8.
10. Aldea GS, Soltow, Lo, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy section in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002;123:742-55.
11. Shapira OM, Aldea GS, Treanor PR, et al. Reduction of allogenic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg. 1998;65:724-30.
12. Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg. 1995;60:1008-14.
13. Ovrum E, Holen EA, Tangen G, et al. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects. Ann Thorac Surg. 1995;60:365-71.
14. Von Segesser LK, Weiss BM, Pasic M, Garcia E, Turina MI. Risk and benefit of low systemic heparinization during open heart operations. Ann Thorac Surg. 1994;58:391-8.
15. Von Segesser LK. Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001;121: 200-1.
16. Wildevuur CRH, Jansen PGM, Bezemer PD, et al. Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits (2nd version). The European working group on heparin coated extracorporeal circulation circuits. Eur J Cardiothorac Surg. 1997;67: 994-1000.
17. Ranucci M, Mazzucco A, Pessotto R, et al. Heparin-coated circuits for high-risk patients: A multicenter, prospective, randomized trial. Ann Thorac Surg. 1999;67:994-1000.
18. Aldea GS, Lilly K, Gaudiani JM, et al. Heparin-bonded circuits improve clinical outcomes in emergency coronary bypass grafting. J Card Surg. 1997;12:389-97.